02 November 2018 | News
Along with the new distribution partnership, BioGX now has sales and customer support in more than 80 countries throughout the world.
Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, announced several new distribution partnerships in the EMEA and Asia-Pacific as it continues to expand its global presence.
"We welcome our new partners and are delighted with the quality of customer relationships our partners bring. As we expand our global footprint, we will continue to partner with companies that share our vision of exemplary customer service and a commitment to represent high quality, innovative products," said Shazi Iqbal, Ph.D., CEO of BioGX.
The creation of these partnerships is part of BioGX's Global Partnership Initiative, launched in January 2018. In addition to the distribution partners listed below, BioGX now has sales and customer support in more than 80 countries throughout the world.
The new Distribution Partners include:
AxonLab - The Netherlands
Detoxicare - The Philippines
Genomica - Spain, Sweden, Finland, Denmark, and Norway
Interlux - Estonia, Latvia, and Lithuania
Isaac Healthcare Solutions - Kuwait
Launch Diagnostics - France
Ngaio - New Zealand and Oceania
Pro-Med Diagnostics - South Africa and Sub-Saharan Africa
Quilaban - Portugal
Servizi Diagnostici - Italy